0001478242-20-000058.txt : 20200805
0001478242-20-000058.hdr.sgml : 20200805
20200805170252
ACCESSION NUMBER: 0001478242-20-000058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200803
FILED AS OF DATE: 20200805
DATE AS OF CHANGE: 20200805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bruehlman Ronald E
CENTRAL INDEX KEY: 0001604076
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35907
FILM NUMBER: 201078434
MAIL ADDRESS:
STREET 1: C/O IMS HEALTH HOLDINGS, INC.
STREET 2: 83 WOOSTER HEIGHTS ROAD
CITY: DANBURY
STATE: CT
ZIP: 06810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IQVIA HOLDINGS INC.
CENTRAL INDEX KEY: 0001478242
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 271341991
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-998-2000
MAIL ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc.
DATE OF NAME CHANGE: 20161003
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc.
DATE OF NAME CHANGE: 20091208
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-08-03
0001478242
IQVIA HOLDINGS INC.
IQV
0001604076
Bruehlman Ronald E
C/O IQVIA HOLDINGS INC.
83 WOOSTER HEIGHTS ROAD
DANBURY
CT
06810
0
1
0
0
See Remarks
Common Stock
2020-08-03
4
A
0
16751
0
A
16751
D
Common Stock
2020-08-04
4
P
0
10000
159.94
A
26751
D
Represents a grant of restricted stock units that will vest in three annual installments beginning on August 3, 2021.
The price reported in Column 4 is a weighted average price for shares purchased in multiple transactions. The purchase prices range from $159.75 to $160.04 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
EVP & interim Chief Financial Officer
/s/ Matthew Gilmartin, Attorney-in-Fact for Ronald E Bruehlman
2020-08-05